NT157 Exerts Antineoplastic Activity by Targeting JNK and AXL Signaling in Lung Cancer Cells

Lung cancer was chosen to explore the NT157 multi-target effects as it was found associated with multiple activated oncogenic pathways relevant to the neoplastic phenotype targets of the drug.